PCI Pharma Investing $365 M To Expand Packaging & Device-Assembly Ops 
By

By
PCI Pharma Services, a Philadelphia, Pennsylvania-based CDMO of drug products and a provider of contract packaging services, is investing more than $365 million in new and expanded facilities in Europe…

Agilent Completes $925-M Acquisition of CDMO BioVectra 
By

By
Agilent Technologies, a Santa Clara, California-based technology company and CDMO of nucleic acid-based active pharmaceutical ingredients (APIs), has completed its $925-million acquisition of BioVectra, a Charlottetown, Prince Edward Island, Canada-based…

Supplier News: Cambrex, Thermo Fisher Scientific, Eurofins CDMO Alphora, Just-Evotec & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Eurofins CDMO Alphora, Cambrex, Ascend Advanced Therapies, Just-Evotec Biologics, Pace Life Sciences, Verdot and ten23 health.   Chemicals/Chemical API Manufacturing * Cambrex, Atinary Technologies…

Global Briefs: Emergent, CSL, Gilead, bluebird bio & More 
By

By
A roundup of news from Emergent BioSolutions, Gilead Sciences and bluebird bio. Highlights below.   Mfg News * Emergent BioSolutions Secures $400 M in US Gov’t Contracts for Smallpox, Mpox Vaccine   *…

Organon To Acquire Roivant Subsidiary Dermavant in $1.2-Bn Deal 
By

By
Organon, the former biosimilars, women’s health and certain legacy established brands from Merck & Co, which were spun off in a separate company in 2021, has agreed to acquire Dermavant…

Hikma Completes Acquisition of Select Assets from Xellia 
By

By
Hikma, a London-based provider of generic injectables, has completed its acquisition of certain R&D, manufacturing and product assets from Xellia Pharmaceuticals, a Copenhagen, Denmark-headquartered specialty pharmaceutical company of anti-infectives, in…

Supplier News: Cambrex, Recipharm, Adare & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Cambrex, Recipharm, Adare Pharma Solutions, Hovione, Thermo Fisher Scientific, Serán Bioscience, BioCentriq, Quotient Sciences,  Lifecore Biomedical, and Biocair.   Chemicals/Chemical API Manufacturing * Cambrex…

Global Briefs: Gilead Sciences, Genesis Therapeutics & Bavarian Nordic 
By

By
A roundup of news from Bavarian Nordic & Gilead Sciences/Genesis Therapeutics. Highlights below.   Mfg News * Bavarian Nordic, Gavi in Mpox Vaccine Pact Partnering News * Gilead, Genesis Therapeutics in AI Drug Development…

Lilly Announces Mfg Expansions in Ireland Totaling $1.8 Bn 
By

By
Eli Lilly and Company has announced a pair of manufacturing expansions in Ireland, totaling $1.8 billion. The company announced a $1-billion expansion of its Limerick, Ireland, site to increase production…

Roche Opens New $1.4-Bn R&D Center 
By

By
Roche has opened a new CHF 1.2-billion ($1.4 billion) pharma research and early development center at its global headquarters in Basel, Switzerland.   The center houses approximately 1,000 laboratory and office…